功能化的脂质体用于鼻腔内输送利沃多巴到大脑
Daria S Gordeeva1, Achraf Sym Tameloucht1, Irina I Semina2
1Institute of pharmacy, Kazan State Medical University, Kazan, Russian Federation.
Drug development and industrial pharmacy
|May 20, 2025
概括
功能化的脂质体显示出对鼻内利沃多巴输送的前景. 增强的脂质体结构改善了鼻腔粘膜的透,这表明帕金森病治疗的潜力.
科学领域:
- 纳米技术纳米技术
- 药品制造 药品制造 药品制造
- 神经科学是一个神经科学.
背景情况:
- 列沃多巴是帕金森病的首要治疗方法,但其向大脑输送具有挑战性.
- 鼻内药物输送提供了一种潜在的替代途径,可以绕过血脑屏障.
- 脂质体是用于药物输送应用的多功能纳米载体.
研究的目的:
- 评估功能化的脂质体作为内鼻输送利沃多巴的载体.
- 研究功能化对脂质体特性和性能的影响.
- 评估这种传递系统在帕金森病治疗中的潜力.
主要方法:
- 传统的和功能化的脂质体 (PEGylated或maleimide-PEG) 使用脂膜水化方法进行制备.
- 脂质体的表征涉及动态光散射和1H-NMR光谱学.
- 研究了粘膜粘合,粘膜透和勒沃多巴释放 (弗朗兹扩散细胞).
- 通过监测大鼠的多巴胺转移抑制来评估体内疗效.
主要成果:
- 脂质体的平均直径为81-91纳米,PDI<0.300,负泽塔潜力.
- 增加的聚乙烯甘醇分子量增加了鼻腔粘膜的透到0.4毫米.
- 列沃多巴释放跟随了Fickian扩散动力学.
- 在体内内鼻腔内给予乐伏多巴,在1小时内抑制了多巴胺的传播.
结论:
- 功能化的脂质体显示出作为有效的鼻内药物载体的潜力.
- 优化的脂质体配方需要进一步研究莱沃多巴的输送.
- 这种方法可能为帕金森病提供一种新的治疗策略.
相关概念视频
Drug Delivery: Parenteral Route
355
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
355
Drug Delivery: Miscellaneous Routes
296
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
296


